查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1835244

髖關節置換植入術市場（依手術方法、固定方法、材料組合、手術類型和最終用戶）—2025-2032 年全球預測

Hip Replacement Implant Market by Surgical Approach, Fixation Method, Material Pairing, Procedure Type, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年髖關節置換植入術市場規模將成長至 127.5 億美元，複合年成長率為 7.77%。

主要市場統計數據
基準年2024年 70億美元
預計2025年 75.6億美元
預測年份：2032年 127.5億美元
複合年成長率（%） 7.77%

為髖關節置換植入術領域提供策略方向，綜合臨床促進因素、技術進步與高階主管採購現實

髖關節置換置換術仍然是肌肉骨骼醫學領域最具影響力的治療方法之一，這得益於人口結構的變化、慢性病負擔的增加以及患者對治療結果和康復速度不斷提升的期望。植入材料和固定技術的進步，加上外科手術的創新，正在為不同類型的患者拓展治療選擇，而醫療服務模式也正在將手術從住院轉移到門診。同時，支付方和醫療機構正在加強對價值的審查，並擴大將臨床證據與購買決策聯繫起來。

臨床醫生和採購主管需要權衡一系列複雜的因素，包括使用壽命、穿戴式、術中效率和總費用。技術應用並非一成不變，地理和機構差異決定了機器人、導航和微創技術的採用。對法律規範和上市後監測的期望也在不斷變化，這使得可靠的臨床數據和長期療效更有價值。這些動態因素正在挑戰製造商、醫療系統和經銷商採取更整合的策略，將產品開發與付款人參與和醫療保健提供者培訓相結合，以確保創新轉化為臨床和經濟效益的可衡量改善。

本執行摘要概述了近期至中期影響競爭定位的關鍵動態，強調需要在研發、上市和營運方面採取協調行動，以應對不斷變化的需求模式，同時保持法規遵從性和臨床醫生的信心。

臨床、技術和供應方面的綜合變化正在重新定義髖植入創新如何轉化為供應商的採用和商業性價值

在材料和技術的不斷進步以及顛覆性數位化能力的推動下，髖植入領域正在加速變革。陶瓷複合材料、高交聯聚乙烯和表面塗層的創新推動了材料科學的進步，這不僅推動了現代軸承性能的提升，也改變了外科醫生的偏好和重新置換方案。手術技術也在不斷發展，隨著醫療服務提供者追求更快的康復時間和更短的住院時間，微創手術和保留組織的入路變得越來越普遍。這種臨床轉變是由診斷成像、增強型術中引導和機器人技術的採用所推動的，這些技術正在改善植入的定位和可重複性。

同時，醫療保健服務正在適應財務和物流壓力。門診手術中心的擴張正在改變器械選擇標準，強調可預測的手術時間和易於盤點的植入。供應鏈彈性正變得越來越重要，促使原始設備製造商 (OEM) 實現採購多元化，並策略性地儲備庫存，以應對市場中斷。報銷模式正朝著事件為基礎的支付方向發展，獎勵器械和照護途徑，從而減少再入院和重複住院。因此，商業策略正在轉向強調療效證據、外科醫生培訓計劃和上市後監測。

要在這一領域取得成功，需要在臨床證據生成、外科醫生數位化以及將產品價值與不斷發展的醫療服務模式相結合的營運機制方面進行全面投資。

2025 年美國關稅對髖關節植入技術採購、定價策略和臨床可近性的營運和策略影響

2025年美國新關稅的實施，標誌著全球髖植入供應動態和籌資策略的重要曲折點。關稅將增加進口零件和成品的到岸成本，迫使製造商和經銷商重新評估其採購足跡和合約結構。為此，許多供應商正在加速近岸外包，將關鍵製造業務轉移到免關稅管轄區，或重新配置零件採購，以最大限度地降低關稅的影響。除了這些營運方面的應對措施外，供應商還正在與醫療系統重新談判契約，以尋求更高的價格透明度和風險分擔安排，從而降低採購成本的增加。

醫院和門診中心面臨著在持續護理和成本控制之間進行權衡的問題。一些機構正在尋求批量折扣、延長保固期和外包模式來管理營運資金，同時維護現有的供應商關係。另一些機構則在實現供應商多元化，例如選擇國內製造商和替代材料組合，以便在不影響臨床療效的情況下提供優惠價格。重要的是，海關環境非常重視供應鏈的透明度和分類的準確性，因為關稅代碼和產品分類對海關責任有重大影響。

從策略角度來看，擁有靈活生產佈局、垂直整合能力和完善監管文件的供應商，能夠更好地吸收或抵銷關稅帶來的成本壓力。具有前瞻性的公司將投資於長期供應商多元化，提升海關和貿易合規能力，並與付款方和供應商合作，建立基於價值的採購安排，以共用短期成本衝擊的負面影響，同時確保獲得臨床所需的解決方案。

以細分市場為中心的情報，揭示手術方法、固定、材料、手術類型和最終用戶的差異化臨床需求、預期設備性能和採購促進因素

對市場進行詳細的細分分析，可以揭示臨床需求、營運可行性和機會的交會點。手術入路分為微創入路和傳統入路，微創入路進一步分為前路入路和後外側入路，傳統入路又進一步分為前路入路和後路入路。每種入路都有其獨特的器械需求、植入幾何形狀和手術全期方案，這些都會影響外科醫師的偏好和醫院的器械庫存決策。例如，微創前路入路通常優先考慮能夠保留肌肉並縮短復健期的植入和器械，而傳統後路入路則可能更傾向於選擇具有成熟長期療效數據且與傳統器械相容性更高的植入。

骨水泥、非骨水泥和混合固定方法之間的差異為不同的患者群體創造了差異化的價值提案。非骨水泥系統強調骨整合和模組化，並通常與先進的表面處理相結合以促進新骨形成。材料組合分為陶瓷-陶瓷、陶瓷-聚乙烯、金屬-金屬和金屬-聚乙烯。陶瓷-陶瓷進一步分為氧化鋁-氧化鋁和氧化鋯-氧化鋯兩種類型，而陶瓷-聚乙烯則進一步分為氧化鋁-聚乙烯和氧化鋯-聚乙烯。金屬-金屬和金屬-聚乙烯組契約樣細分為鈷鉻或鈦組合以及匹配或聚乙烯組合。這些材質組合會影響磨損行為、雜訊風險、影像偽影輪廓和重新置換策略，進而影響臨床醫師的選擇和採購談判。

手術類型分為初次手術和重新置換手術，初次手術又分為雙側手術和單側手術，重新置換手術又分為髀臼修復手術、雙側修復手術和股骨重新置換手術。不同手術類型的技術複雜性、庫存要求和成本影響差異很大，重新置換手術通常需要模組化擴展和更專業的植入。門診手術中心和醫院的最終用戶細分不同，因此購買標準也不同。門診手術中心優先考慮支援快速吞吐和可預測結果的植入，而醫院則重視更廣泛的病例組合靈活性和縱向登記資料。這種綜合細分為產品開發、臨床教育和報銷參與提供了有針對性的路徑，與每個細分市場的臨床和營運重點一致。

比較影響美洲、歐洲、中東和非洲地區以及亞太地區監管策略、採購重點和實施路徑的區域動態

區域動態顯著影響採用曲線、監管途徑和商業性重點，為市場進入和擴張制定了清晰的策略。在美洲，成熟的報銷生態系統和門診手術中心的高滲透率正在加速人們對可減少住院時間並支持快速康復通訊協定的植入的興趣。該地區還強調穩健的縱向結果和註冊，這增強了臨床醫生和付款人對成熟技術的信心。美洲的監管參與和付款人談判通常優先考慮真實世界證據和基於價值的契約，以使產品採用與財務課責保持一致。

歐洲、中東和非洲的管理體制和報銷框架各不相同，因此需要製定針對特定地區的策略。一些歐洲市場實行集中採購機制和比較有效性評估，傾向具有強力臨床證據且經濟高效的解決方案。中東市場越來越容易接受捆綁培訓和服務的高階技術，而許多非洲市場則優先考慮價格實惠和供應可靠性。因此，供應商必須調整其產品以適應當地採購標準，並投資於有針對性的臨床和商業性支持，以克服市場碎片化。

亞太地區的特點是銷售量快速成長、手術能力不斷提升，且各國醫療體系的成熟度參差不齊。一些國家在採用本地製造能力和技術創新方面處於領先地位，而另一些國家仍在建立手術能力和註冊基礎設施。在臨床醫生專業知識不斷提升和私人手術設施不斷擴張的推動下，該地區在採購成本敏感型產品的同時，也迅速採用了先進材料和數位化手術器械。這些地區差異凸顯了差異化市場策略的必要性，這些策略需要考慮監管的複雜性、本地製造能力，以及在高階產品和具成本效益產品之間取得平衡。

競爭動態和供應商策略將產品創新、臨床證據產生和服務主導的差異化相結合，以在價值驅動的環境中獲勝

供應商生態系統不斷發展，現有企業不斷拓寬產品供應，新興企業透過材料創新、模組化架構和服務主導提案開拓利基市場。競爭差異化越來越依賴臨床證據、外科醫生培訓和支持，以及涵蓋植入物本身、儀器儀表、數位化規劃工具和售後服務等全方位植入的結合。該行業普遍採取的策略行動包括：垂直整合以確保關鍵零件供應；與機器人和導航開發商建立選擇性合作夥伴關係；以及投資臨床註冊專案以強化安全性和有效性聲明。

商業模式也在多樣化。一些供應商強調捆綁解決方案和基於療程的定價，直接與醫療服務提供者和付款人合作，根據療效調整獎勵。另一些供應商則優先與外科醫生密切合作，透過教育中心、屍體實驗室和監考計畫來推廣手術的採用。配送和物流能力也是差異化因素，尤其是在供應鏈可靠性影響採購決策的地區。能夠提供可預測的服務水準、靈活的合約安排和快速回應的臨床支援的組織在採購談判中將獲得競爭優勢。

成功的市場參與企業將取決於能否在短期商業性利益與長期投資（在證據生成和臨床醫生夥伴關係）之間取得平衡。將產品性能與卓越營運和可證明的療效相結合的公司將佔據有利地位，能夠影響處方並確保持續的優先使用。

製造商、醫療保健提供者和經銷商應採取切實可行的優先行動，以增強韌性、加速採用並在臨床和政策轉變中獲取價值

產業領導者應採取多維度策略，將產品創新與營運韌性和付款人參與度相結合。首先，實現製造和供應商關係多元化，以降低貿易政策波動帶來的風險，並確保向大批量生產中心穩定供應。建立區域生產能力或多源關鍵部件，以保持連續性並確保成本可預測性。其次，優先投資微創平台和模組化植入系統，以滿足對更快恢復和多樣化重新置換方案日益成長的需求。全面的外科醫生培訓、術中規劃工具和結果追蹤可以補充產品發布，縮短引進週期，並建立真實世界證據。

第三，我們將積極與付款方合作，制定基於價值的方案，以獎勵療效和成本控制。我們將建立試點項目，展示住院時間、再入院率和再手術率的降低，並利用這些成果來協商優先產品路徑。第四，我們將最佳化門診手術中心的商業模式，將其與支援提高吞吐量、簡化器械和即時供應的捆綁服務相結合。第五，我們將加強上市後監測和數據分析能力，以便及早發現績效趨勢，並支持監管提交和競標流程。最後，我們將透過投資海關專業知識、提高關稅分類準確性和靈活的物流，為法規和貿易政策的變化製定情境規劃，以在不斷變化的外部環境中保持競爭力。

實施這些行動需要研發、供應鏈、臨床和商業團隊的跨學科協調，以確保對產品和流程的投資能帶來臨床結果和財務績效的可衡量的改善。

調查方法的透明度：描述支撐我們研究結果的主要和次要證據收集、三角測量方法和品管

本分析基於嚴格的混合方法研究設計，將主要相關人員的參與與全面的二手證據整合相結合。主要資訊包括與骨科醫生、醫院採購負責人、門診手術中心管理人員、監管專家和高級商務主管進行結構化訪談，以掌握關於臨床偏好、採購動態和營運挑戰的第一手觀點。這些定性見解輔以同行評審的臨床文獻、設備註冊、監管提交文件和程序指南的審查，以檢驗技術性能聲明和長期安全訊號。

二次研究涵蓋公共文件、貿易數據和臨床實踐建議，並模擬了監管變化、關稅效應和採用模式之間的相互作用。採用數據三角測量法來協調差異，並確保結論是基於多個獨立資訊來源。品質保證程序包括訪談記錄的交叉檢驗、證據選擇的方法學審核以及臨床和市場進入專家的內部同行評審。我們承認存在證據缺口的局限性，尤其是對於缺乏長期結果數據的新材料或新型微創技術的組合。

總體而言，該調查方法在臨床洞察的深度和商業性知識的廣度之間取得平衡，透明地記錄假設和證據來源，同時得出可靠且可行的結論。

整合高階主管必須協調的策略重點和風險考慮，以將創新轉化為可衡量的臨床和商業性成果

人口結構需求、材料和手術創新以及醫療服務模式的轉變，使髖植入產業正處於曲折點，戰略遠見將獲得回報。臨床進展和數位化應用為改善患者治療效果和營運效率創造了機會，但也提高了證據產生、供應鏈敏捷性以及與付款人的商業性協調的標準。關稅相關的成本壓力和區域監管的複雜性進一步凸顯了對靈活應變的生產佈局和積極主動的貿易合規性的必要性。

整合臨床、商業和營運策略的相關人員最有可能獲得持續價值。這需要優先考慮可靠的臨床證據，投資外科醫生培訓和數位化規劃工具，實現供應鏈多元化，並讓付款方參與基於價值的安排。應用這些原則不僅有助於製造商保護淨利率，還能透過可證明的療效和靈活的商業模式擴大可及性，並使醫療服務提供者能夠最佳化護理路徑，從而改善康復並提高成本效益。

總的來說，該產業的近期發展軌跡將取決於組織將創新轉化為檢驗的臨床效益和營運可靠性的速度，而跨職能協作執行是成功的關鍵能力。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 實施人工智慧驅動的術前計畫和預測模型，以最佳化髖置換術的結果
  • 針對特定患者的 3D 列印髖植入的需求日益成長，以改善其解剖貼合度和癒合效果
  • 結合機器人輔助微創技術的精準髖關節置換手術
  • 利用先進的多模態疼痛管理擴大門診髖關節置換手術
  • 促進骨整合和降低感染風險的生物活性植入塗層的開發正在興起
  • 擴大採用模組化雙活動植入設計，以最大限度地減少脫位並提高穩定性
  • 瓷質對瓷質接合面和交聯聚乙烯軸承表面的進步可延長植入的壽命
  • 擴大使用遠端醫療平台進行術後監測和個人化物理治療依從性
  • 透過植入製造商和研究機構之間的策略合作，實現先進植入材料的創新

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8.髖關節置換植入術市場（依手術方法）

  • 微創
    • 前部最小值
    • 後外側最小值
  • 傳統的
    • 前入路
    • 後入路

9.髖關節置換植入術市場（依固定方法）

  • 水泥
  • 非骨水泥
  • 混合

第10章髖關節置換植入術市場（依材料組合）

  • 陶瓷與陶瓷
    • 氧化鋁與氧化鋁
    • 鋯石 vs 鋯石
  • 聚乙烯與陶瓷
    • 聚乙烯與氧化鋁
    • 聚乙烯與氧化鋯
  • 金屬對金屬
    • 鈷鉻合金與鈷鉻合金
    • 鈦與鈦
  • 聚乙烯與金屬
    • 聚乙烯與鈷鉻
    • 聚乙烯與鈦

第 11 章髖關節置換植入術市場（依手術類型）

  • 基本的
    • 雙方
    • 一邊
  • 重新置換
    • 髀臼翻修手術
    • 重新置換手術
    • 股骨重新置換手術

第 12 章髖關節置換植入術市場（依最終使用者分類）

  • 門診手術中心
  • 醫院

13.髖關節置換植入術市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 14 章髖關節置換植入術市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15.髖關節置換植入術市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • DePuy Synthes, Inc.
    • Zimmer Biomet Holdings, Inc.
    • Stryker Corporation
    • Smith & Nephew plc
    • Exactech, Inc.
    • DJO Global, Inc.
    • B. Braun Melsungen AG
    • MicroPort Scientific Corporation
    • Medacta International SA
    • Corin Group PLC
Product Code: MRR-437E9896A56D

The Hip Replacement Implant Market is projected to grow by USD 12.75 billion at a CAGR of 7.77% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.00 billion
Estimated Year [2025] USD 7.56 billion
Forecast Year [2032] USD 12.75 billion
CAGR (%) 7.77%

A strategic orientation to the hip replacement implant sector that synthesizes clinical drivers, technological advances, and procurement realities for executives

Hip arthroplasty continues to be one of the most impactful interventions in musculoskeletal care, driven by demographic shifts, rising chronic disease burden, and evolving expectations for patient outcomes and recovery speed. Advances in implant materials and fixation techniques are converging with surgical innovation to expand treatment options for heterogeneous patient profiles, while healthcare delivery models are migrating procedures from inpatient wards to ambulatory settings. At the same time, payers and providers are imposing greater scrutiny on value, leading to a tighter coupling between clinical evidence and purchasing decisions.

Clinicians and procurement leaders are navigating a complex matrix of trade-offs that include longevity, wear performance, intraoperative efficiency, and total episode cost. Technology adoption is not monolithic; geographical and institutional differences shape uptake of robotics, navigation, and minimally invasive techniques. Regulatory frameworks and post-market surveillance expectations are also rising, creating a premium for robust clinical data and longitudinal outcomes. These forces collectively demand that manufacturers, health systems, and distributors adopt more integrated strategies that connect product development with payer engagement and provider training, ensuring that innovations translate into measurable improvements in clinical and economic outcomes.

This executive summary frames the critical dynamics that will influence competitive positioning over the near to medium term. It emphasizes the need for coordinated action across R&D, market access, and operations to respond to shifting demand patterns while sustaining regulatory compliance and clinician trust.

Compounding clinical, technological, and supply-side shifts that are redefining how hip implant innovation translates into provider adoption and commercial value

The hip implant landscape is undergoing a period of accelerated transformation as incremental improvements in materials and technique compound with disruptive digital capabilities. Material science progress-driven by innovations in ceramic composites, highly crosslinked polyethylene, and surface coatings-has extended the performance envelope of modern bearings while simultaneously altering surgeon preferences and revision profiles. Surgical technique is also evolving; minimally invasive approaches and tissue-sparing access routes are becoming more prevalent as providers seek faster recovery times and reduced length of stay. These clinical shifts have been catalyzed by enhanced imaging, intraoperative guidance, and adoption of robotics, which collectively improve implant positioning and reproducibility.

Concurrently, care delivery is adjusting to financial and logistical pressures. The expansion of ambulatory surgical centers has changed the calculus for device selection, with a premium on implants that enable predictable operative times and straightforward inventory management. Supply chain resilience has come into sharper focus, prompting OEMs to diversify sourcing and hold strategic inventories to guard against disruptions. Reimbursement models are increasingly oriented toward episode-based payments, incentivizing devices and care pathways that reduce readmissions and revisions. As a result, commercial strategies are adapting to emphasize outcome evidence, surgeon training programs, and post-market surveillance.

Taken together, these transformative shifts reinforce a cross-functional imperative: success in this sector requires integrated investments in clinical evidence generation, digital enablement for surgeons, and operational mechanisms that align product value with evolving care delivery models.

Operational and strategic implications of the 2025 United States tariff measures on sourcing, pricing strategies, and clinical access to hip implant technologies

The imposition of new tariffs by the United States in 2025 has introduced a significant inflection point for global hip implant supply dynamics and procurement strategies. Tariff measures increase landed costs for imported components and finished devices, prompting manufacturers and distributors to reassess sourcing footprints and contract structures. In response, many suppliers accelerate nearshoring initiatives, migrate critical manufacturing steps to tariff-safe jurisdictions, or reconfigure component sourcing to minimize customs exposure. These operational responses are complemented by contract renegotiations with health systems that seek greater price transparency and shared risk arrangements to mitigate increased procurement costs.

Hospitals and ambulatory centers confront trade-offs between continuity of care and cost containment. Some institutions preserve existing supplier relationships but push for volume discounts, extended warranties, or consignment models to manage working capital. Others diversify their supplier base to include domestic manufacturers or alternative material pairings that yield favorable pricing without compromising clinical outcomes. Importantly, the tariff environment has placed a premium on supply-chain visibility and classification accuracy, as tariff codes and product categorizations materially affect duty burdens.

From a strategic perspective, suppliers with flexible manufacturing footprints, vertically integrated capabilities, and established regulatory dossiers are better positioned to absorb or offset tariff-driven cost pressures. Forward-looking organizations invest in long-term supplier diversification, invest in customs and trade compliance capabilities, and collaborate with payers and providers to structure value-based purchasing arrangements that share the downside of short-term cost shocks while preserving access to clinically preferred solutions.

Segment-centric intelligence revealing differentiated clinical needs, device performance expectations, and procurement drivers across surgical, fixation, material, procedure, and end-user dimensions

Analyzing the market through detailed segmentation illuminates where clinical need, operational feasibility, and commercial opportunity intersect. Surgical approach divides into minimally invasive and traditional pathways, with the minimally invasive category further distinguishing anterior minimal and posterolateral minimal techniques, and the traditional category distinguishing anterior and posterior approaches. Each pathway introduces unique instrumentation needs, implant geometries, and perioperative protocols that influence surgeon preference and hospital inventory decisions. Minimally invasive anterior techniques, for example, often prioritize implants and instruments that facilitate muscle-sparing access and quicker rehabilitation, whereas traditional posterior approaches may favor implants with established long-term outcome data and broader compatibility with legacy instrumentation.

Fixation method segmentation-cemented, cementless, and hybrid-creates differentiated value propositions for distinct patient cohorts. Cementless systems emphasize osseointegration and modularity, often paired with advanced surface treatments to promote bone in-growth, whereas cemented options remain relevant for specific anatomical or bone-quality considerations. Material pairing segmentation spans ceramic on ceramic, ceramic on polyethylene, metal on metal, and metal on polyethylene configurations. Ceramic on ceramic further divides into alumina on alumina and zirconia on zirconia variants, while ceramic on polyethylene differentiates alumina on polyethylene and zirconia on polyethylene. Metal on metal and metal on polyethylene combinations are similarly subdivided by cobalt chrome or titanium pairings against matching or polyethylene counterparts. These material permutations affect wear behavior, squeaking risk, imaging artifact profiles, and revision strategies, influencing both clinician selection and procurement negotiations.

Procedure type segmentation separates primary from revision procedures, with the primary category subdivided into bilateral and unilateral cases and the revision category differentiated into acetabular, dual, and femoral revisions. The technical complexity, inventory requirements, and cost implications vary substantially across these procedure types, with revision cases typically necessitating expanded modularity and more specialized implants. End-user segmentation between ambulatory surgical centers and hospitals drives divergent purchasing criteria; ambulatory settings prioritize implants that support rapid throughput and predictable outcomes, while hospitals weigh broader case-mix flexibility and long-term registry data more heavily. Integrating these segmentation lenses reveals targeted pathways for product development, clinical education, and reimbursement engagement that align with each segment's distinct clinical and operational priorities.

Comparative regional dynamics that influence regulatory strategy, procurement priorities, and adoption pathways across the Americas, EMEA, and Asia-Pacific

Regional dynamics shape adoption curves, regulatory pathways, and commercial priorities in meaningful ways, creating distinct playbooks for market entry and expansion. In the Americas, a mature reimbursement ecosystem and a high penetration of ambulatory surgical centers accelerate interest in implants that reduce length of stay and support rapid recovery protocols. This region also places a strong emphasis on robust longitudinal outcomes and registries, which reinforce clinician and payer confidence in proven technologies. Regulatory engagement and payer negotiations in the Americas often prioritize real-world evidence and value-based contracting to align product adoption with fiscal accountability.

Across Europe, the Middle East & Africa, heterogeneous regulatory regimes and varying reimbursement frameworks necessitate region-specific strategies. Several European markets maintain centralized procurement mechanisms and comparative effectiveness evaluations that favor cost-effective solutions with strong clinical evidence. Middle Eastern markets are increasingly receptive to premium technologies when bundled with training and service commitments, while many African markets prioritize affordability and supply reliability. Vendors must therefore calibrate offerings to local procurement norms and invest in targeted clinical and commercial support to overcome market fragmentation.

The Asia-Pacific region is characterized by rapid volume growth, expanding surgical capacity, and divergent maturity across national health systems. Certain countries lead in local manufacturing capabilities and innovation adoption, while others are still building procedural capacity and registry infrastructure. Cost-sensitive procurement coexists with pockets of rapid adoption for advanced materials and digital surgical tools, driven by rising clinician expertise and expanding private-sector surgical facilities. These regional contrasts underscore the need for differentiated go-to-market strategies that account for regulatory complexity, local manufacturing potential, and the balance between premium and cost-effective product tiers.

Competitive dynamics and supplier playbooks that combine product innovation, clinical evidence generation, and service-led differentiation to win in a value-focused environment

The supplier ecosystem continues to evolve, with incumbents refining product breadth and emerging players carving niche positions through material innovation, modular architectures, or service-led propositions. Competitive differentiation increasingly hinges on a combination of clinical evidence, surgeon training and support, and integrated offerings that extend beyond the implant itself to include instrumentation, digital planning tools, and aftermarket services. Strategic behaviors observed across the sector include vertical integration to secure critical component supply, selective partnerships with robotics and navigation developers, and investment in clinical registry programs to reinforce safety and effectiveness claims.

Commercial models are also diversifying. Some suppliers emphasize bundled solutions and episode-based pricing, collaborating directly with providers and payers to align incentives around outcomes. Others prioritize high-touch surgeon engagement through education centers, cadaver labs, and proctoring programs to accelerate technique adoption. Distribution and logistics capabilities are a differentiator as well, particularly in regions where supply-chain reliability influences purchasing decisions. Organizations that offer predictable service levels, flexible consignment arrangements, and responsive clinical support gain a competitive edge in procurement discussions.

Success for market participants depends on balancing near-term commercial wins with long-term investments in evidence generation and clinician partnerships. Firms that combine product performance with operational excellence and demonstrable outcomes are better placed to influence formularies and secure sustained preferential use.

Practical and prioritized actions for manufacturers, providers, and distributors to strengthen resilience, accelerate adoption, and capture value amid clinical and policy shifts

Industry leaders should adopt a multi-dimensional strategy that aligns product innovation with operational resilience and payer engagement. First, diversify manufacturing and supplier relationships to reduce exposure to trade-policy volatility and ensure uninterrupted supply to high-volume centers. Establishing regional production capabilities or multi-sourcing for critical components will preserve continuity while delivering cost predictability. Second, prioritize investments in minimally invasive platforms and modular implant systems that address growing demand for faster recovery and versatile revision options. Complement product launches with comprehensive surgeon training, intraoperative planning tools, and outcomes tracking to shorten adoption cycles and build real-world evidence.

Third, engage payers proactively to develop value-based arrangements that reward outcomes and cost containment. Structure pilot programs that demonstrate reductions in length of stay, readmission rates, and revision incidence, and leverage these results to negotiate preferred-product pathways. Fourth, optimize commercial models for ambulatory surgical centers by tailoring bundles that support higher throughput, simplified instrumentation, and just-in-time supply. Fifth, enhance post-market surveillance and data analytics capabilities to detect performance trends early and to support regulatory submissions and tender processes. Finally, scenario-plan for regulatory and trade-policy changes by investing in customs expertise, tariff classification accuracy, and flexible logistics to maintain competitiveness under shifting external conditions.

Implementing these actions requires cross-functional coordination across R&D, supply chain, clinical affairs, and commercial teams, ensuring that investments in product and process translate into measurable improvements in clinical outcomes and financial performance.

Methodological transparency describing primary and secondary evidence collection, triangulation techniques, and quality controls that underpin the executive findings

The analysis draws on a rigorous mixed-methods research design combining primary stakeholder engagement with comprehensive secondary evidence synthesis. Primary inputs include structured interviews with orthopedic surgeons, hospital procurement leaders, ambulatory surgical center administrators, regulatory specialists, and senior commercial executives to capture firsthand perspectives on clinical preferences, purchasing dynamics, and operational challenges. These qualitative insights are complemented by a review of peer-reviewed clinical literature, device registries, regulatory filings, and procedural guidelines to validate technical performance claims and long-term safety signals.

Secondary research encompassed public policy documents, trade data, and clinical practice recommendations to model the interaction between regulatory changes, tariff effects, and adoption patterns. Data triangulation was applied to reconcile divergent viewpoints and to ensure that conclusions are grounded in multiple independent sources. Quality assurance procedures included cross-validation of interview transcripts, methodological audits of evidence selection, and internal peer review by clinical and market-access experts. Limitations were acknowledged where evidence gaps exist, particularly in newer material pairings and emerging minimally invasive techniques that lack long-duration outcome data.

Overall, the methodology balanced depth of clinical insight with breadth of commercial intelligence, enabling robust, actionable conclusions while transparently documenting assumptions and evidence sources.

Synthesis of strategic priorities and risk considerations that executives must align to convert innovation into measurable clinical and commercial outcomes

The convergence of demographic demand, materials and surgical innovation, and shifting care-delivery models positions the hip implant sector at an inflection point that rewards strategic foresight. Clinical advances and digital enablement create opportunities to improve patient outcomes and operational efficiency, but they also raise the bar for evidence generation, supply-chain agility, and commercial alignment with payers. Tariff-related cost pressures and regional regulatory complexity further emphasize the need for adaptable manufacturing footprints and proactive trade compliance.

Stakeholders that integrate clinical, commercial, and operational strategies will be best positioned to capture sustained value. This requires prioritizing robust clinical evidence, investing in surgeon training and digital planning tools, diversifying supply chains, and engaging payers in value-based arrangements. By applying these principles, manufacturers can not only protect margins but also expand access through demonstrable outcomes and flexible commercial models, while providers can optimize care pathways that deliver improved recovery and cost-effectiveness.

Taken together, the sector's near-term trajectory will be determined by the speed at which organizations translate innovation into validated clinical benefit and operational reliability, making coordinated cross-functional execution the defining capability for success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of AI-driven preoperative planning and predictive modeling to optimize hip replacement outcomes
  • 5.2. Growing demand for patient-specific 3D-printed hip implants to enhance anatomical fit and recovery
  • 5.3. Integration of robotic-assisted minimally invasive techniques for precise hip replacement procedures
  • 5.4. Expansion of outpatient hip replacement surgeries supported by advanced multimodal pain management
  • 5.5. Surge in development of bioactive implant coatings to accelerate osseointegration and reduce infection risk
  • 5.6. Rising adoption of modular dual mobility hip implant designs to minimize dislocation and improve stability
  • 5.7. Evolution of ceramic-on-ceramic and crosslinked polyethylene bearing surfaces to extend implant longevity
  • 5.8. Increasing use of telemedicine platforms for postoperative monitoring and personalized physical therapy adherence
  • 5.9. Strategic collaborations between implant manufacturers and research institutions to innovate advanced implant materials

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hip Replacement Implant Market, by Surgical Approach

  • 8.1. Minimally Invasive
    • 8.1.1. Anterior Minimal
    • 8.1.2. Posterolateral Minimal
  • 8.2. Traditional
    • 8.2.1. Anterior Approach
    • 8.2.2. Posterior Approach

9. Hip Replacement Implant Market, by Fixation Method

  • 9.1. Cemented
  • 9.2. Cementless
  • 9.3. Hybrid

10. Hip Replacement Implant Market, by Material Pairing

  • 10.1. Ceramic on Ceramic
    • 10.1.1. Alumina on Alumina
    • 10.1.2. Zirconia on Zirconia
  • 10.2. Ceramic on Polyethylene
    • 10.2.1. Alumina on Polyethylene
    • 10.2.2. Zirconia on Polyethylene
  • 10.3. Metal on Metal
    • 10.3.1. Cobalt Chrome on Cobalt Chrome
    • 10.3.2. Titanium on Titanium
  • 10.4. Metal on Polyethylene
    • 10.4.1. Cobalt Chrome on Polyethylene
    • 10.4.2. Titanium on Polyethylene

11. Hip Replacement Implant Market, by Procedure Type

  • 11.1. Primary
    • 11.1.1. Bilateral
    • 11.1.2. Unilateral
  • 11.2. Revision
    • 11.2.1. Acetabular Revision
    • 11.2.2. Dual Revision
    • 11.2.3. Femoral Revision

12. Hip Replacement Implant Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals

13. Hip Replacement Implant Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Hip Replacement Implant Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Hip Replacement Implant Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. DePuy Synthes, Inc.
    • 16.3.2. Zimmer Biomet Holdings, Inc.
    • 16.3.3. Stryker Corporation
    • 16.3.4. Smith & Nephew plc
    • 16.3.5. Exactech, Inc.
    • 16.3.6. DJO Global, Inc.
    • 16.3.7. B. Braun Melsungen AG
    • 16.3.8. MicroPort Scientific Corporation
    • 16.3.9. Medacta International SA
    • 16.3.10. Corin Group PLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. HIP REPLACEMENT IMPLANT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. HIP REPLACEMENT IMPLANT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. HIP REPLACEMENT IMPLANT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2024 (USD MILLION)
  • TABLE 292. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2025-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEM